98%
921
2 minutes
20
Drug interactions are a significant and integral part of the concept of medication-related adverse events, whether referring to potential interactions or those currently observed in real-world conditions. The high global consumption of antibiotics and their pharmacokinetic and pharmacodynamic mechanisms make antibiotic-drug interactions a key element that requires continuous study due to their clinical relevance. In the present work, the current state of knowledge on antibiotic-drug interactions, which are less studied than other drug-drug interactions despite their frequent use in acute settings, has been consolidated and updated. The focus was on the interactions of the commonly used antibiotics in clinical practice, on the characteristics of the geriatric population susceptible to interactions, and on the impact of online drug interaction checkers. Additionally, strategies for optimizing the management of these interactions, including spacing out administrations, monitoring, or avoiding certain combinations, are suggested. Sustained research and careful monitoring are critical for improving antibiotic safety and efficacy, especially in susceptible populations, to enhance precision in managing antibiotic-drug interactions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505481 | PMC |
http://dx.doi.org/10.3390/antibiotics13100938 | DOI Listing |
Sci Rep
August 2025
Department of Chemistry, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.
The investigation of the impact of different additives on the aggregation behavior of drug-surfactant mixtures is highly important to improve pharmaceutical formulations. This study reveals the micellization characteristics of sodium dodecyl sulfate (NaDS) with ofloxacin (OFC) drug different pH and in the occurrence of different electrolytes (KCl, KNO, KHSO, and KSO) media at temperatures from 298.15 to 323.
View Article and Find Full Text PDFBackground: In present days we have the possibility to use new antibiotic drug cefiderocol for the treatment of multiple drug resistant bacterial infections. This infections are the result of preceding and repeating antibiotic therapy mainly in immunocompromised patients.
Case: In our case report we present a young woman with acute leukemia with complicated infection in the perianal and rectal area with sepsis development caused by Pseudomonas aeruginosa with lower sensitivity for carbapenems at the early time of allogeneic transplantation of hematopoiesis due to acute leukemia, when she is under the negative influence of chemotherapy and immunosuppressive drugs.
J Hazard Mater
September 2025
Key Laboratory of Pollution Processes and Environmental Criteria (Ministry of Education), Nankai International Advanced Research Institute (Shenzhen Futian), Tianjin Key Laboratory of Environmental Remediation and Pollution Control, College of Environmental Science and Engineering, Nankai University
The dissemination of antibiotic resistance genes (ARGs) is a growing global health concern. This study investigates how the chiral enantiomers of the non-antibiotic drug naproxen (NAP) influence ARG dissemination in biofilms. Metagenomic sequencing and binning analyses revealed that NAP enantiomers selectively enriched ARGs and their bacterial hosts, enhancing resistance to specific antibiotics.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
June 2025
College of Medical Informatics, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Objective: Older patients with type 2 diabetes mellitus (T2DM) often face severe health challenges. This study aims to develop and validate a predictive model for estimating in-hospital death risk in this population.
Methods: Clinical data of 17,421 patients with T2DM aged ≥ 65 years admitted to six hospitals in southwest China were collected retrospectively.
Clin Pharmacol Drug Dev
August 2025
Phase I Clinical Trial Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Sitafloxacin is a new antibiotic drug belonging to the fourth generation quinolone antibiotics. The aim of this study was to evaluate the pharmacokinetics (PK), safety profiles, and bioequivalence of test and reference 50-mg sitafloxacin tablets under fasting and fed conditions. The PK parameters, which were calculated with noncompartmental model, including maximum concentration, area under the concentration-time curve (AUC) from time 0 to the last quantifiable concentration, and AUC from time 0 to infinity.
View Article and Find Full Text PDF